MYUNGMOON Pharm co.,Ltd (KRX: 017180)

MYUNGMOON Pharm co.,Ltd Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	8,854	7,962	4,858	6,813	4,553	572.14
Short-Term Investments	2,860	3,650	5,065	3,620	6,218	6,627
Trading Asset Securities	52.54	52.65	61.67	83.95	2,317	1,287
Cash & Short-Term Investments	11,767	11,664	9,984	10,517	13,088	8,486
Cash Growth	14.41%	16.83%	-5.06%	-19.65%	54.24%	-4.55%
Accounts Receivable	35,337	33,489	29,456	27,530	29,848	59,072
Other Receivables	5,097	4,243	3,606	2,171	5,229	4,346
Receivables	40,684	38,846	34,673	30,281	35,556	63,698
Inventory	31,413	30,280	25,660	26,032	30,246	26,079
Prepaid Expenses	128.32	189.83	184.71	504.29	1,424	1,649
Other Current Assets	340.77	455.72	205.58	132.32	263.02	829.92
Total Current Assets	84,333	81,436	70,707	67,466	80,577	100,742
Property, Plant & Equipment	138,524	140,196	141,777	142,861	149,944	154,202
Long-Term Investments	2,435	1,540	4,457	3,245	2,156	3,709
Goodwill	-	-	-	-	434.42	434.42
Other Intangible Assets	468.62	267.49	318.47	247.39	330.03	569.7
Long-Term Deferred Tax Assets	8,903	8,109	8,168	4,273	4,273	4,154
Other Long-Term Assets	4,937	5,001	5,022	5,170	5,254	631
Total Assets	239,600	236,549	230,450	223,263	243,025	264,442
Accounts Payable	19,306	16,746	15,677	13,633	15,905	16,683
Accrued Expenses	15,735	16,349	11,848	12,124	9,658	8,285
Short-Term Debt	47,054	74,607	73,503	75,657	82,397	89,334
Current Portion of Long-Term Debt	1,493	1,907	1,306	1,269	7,624	3,065
Current Portion of Leases	758.78	922.99	1,045	1,249	1,071	464.77
Current Income Taxes Payable	65.87	-	118.42	164.35	948.76	4,748
Other Current Liabilities	6,209	5,840	7,325	8,992	7,717	10,803
Total Current Liabilities	90,621	116,373	110,821	113,088	125,320	133,382
Long-Term Debt	43,673	12,584	6,092	4,957	6,388	23,633
Long-Term Leases	154.03	460.2	1,212	998.7	1,314	1,181
Long-Term Deferred Tax Liabilities	3,521	3,521	3,521	3,706	3,706	3,706
Other Long-Term Liabilities	2,157	1,652	270.67	827.67	523.19	2,268
Total Liabilities	153,949	147,794	135,182	137,389	152,250	184,246
Common Stock	16,977	16,977	16,977	16,977	16,977	12,270
Additional Paid-In Capital	35,178	35,178	35,178	77,313	77,171	43,656
Retained Earnings	3,253	6,031	11,425	-39,976	-33,723	-8,271
Treasury Stock	-1,215	-1,215	-540.01	-540.01	-540.01	-540.01
Comprensive Income & Other	26,483	26,483	26,483	26,483	27,317	29,394
Total Common Equity	80,675	83,453	89,522	80,257	87,201	76,510
Minority Interest	4,976	5,302	5,745	5,617	3,574	3,686
Shareholders' Equity	85,651	88,755	95,267	85,874	90,775	80,196
Total Liabilities & Equity	239,600	236,549	230,450	223,263	243,025	264,442
Total Debt	93,133	90,482	83,157	84,130	98,794	117,677
Net Cash (Debt)	-81,366	-78,818	-73,173	-73,614	-85,706	-109,192
Net Cash Per Share	-2443.51	-2340.26	-2164.50	-2177.55	-2927.71	-4476.47
Filing Date Shares Outstanding	33.53	33.53	33.81	33.81	33.81	24.39
Total Common Shares Outstanding	33.53	33.53	33.81	33.81	33.81	24.39
Working Capital	-6,288	-34,937	-40,115	-45,622	-44,743	-32,641
Book Value Per Share	2406.24	2489.11	2648.13	2374.06	2579.48	3136.62
Tangible Book Value	80,206	83,186	89,204	80,010	86,437	75,505
Tangible Book Value Per Share	2392.26	2481.14	2638.71	2366.74	2556.86	3095.46
Land	74,397	74,397	74,397	74,726	77,436	79,706
Buildings	61,545	61,545	58,194	58,325	59,310	59,214
Machinery	32,410	32,325	30,828	29,991	33,626	34,160
Construction In Progress	2,301	2,191	3,418	2,365	2,949	3,756

Source: S&P Capital IQ. Standard template. Financial Sources.